| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Hereditary Tumor Research Project [M. M., T. Ii., K. H., R. I.] and Departments of Surgery [M. Y., T. M., M. T.], Pathology [T. H.], and Neurosurgery [N. S.], Tokyo Metropolitan Komagome Hospital, Tokyo 113-8677; Hyogo College of Medicine, Hyogo 663-8501 [K. T., J. U.]; Keio University, Tokyo 160-8582 [N. K.]; Institute of Molecular Oncology, Showa University, Tokyo 142-8666 [M. M., T. Ii., T. K.]; and Kyoundo Hospital Sasaki Institute, Tokyo 101-0062 [T. Iw.], Japan
Peutz-Jeghers syndrome (PJS) is characterized by multiple gastrointestinal hamartomatous polyps, mucocutaneous melanin deposition, and increased risk of cancer, mainly in the gastrointestinal tract. We examined mutations of the LKB1, ß-catenin, APC, K-ras, and p53 genes in 27 gastrointestinal hamartomatous polyps from 10 patients in nine PJS families. Of these hamartomatous polyps, one intestinal polyp had an adenomatous lesion, and one gastric polyp contained adenomatous and carcinomatous lesions. Germ-line mutations of the LKB1 gene were detected in six PJS families. Somatic mutations of the LKB1 gene were found in 5 polyps, whereas loss of heterozygosity (LOH) at the LKB1 locus at 19p was seen in 14 other polyps. In adenomatous lesions microdissected from hamartomatous polyps, both ß-catenin mutation and 19p LOH were detected. Furthermore, a carcinomatous lesion in a gastric hamartomatous polyp was found to contain a mutation of the p53 gene and LOH at the p53 locus in addition to LOH at the LKB1 locus and a ß-catenin mutation. K-ras mutations were detected in a few polyps, whereas no APC mutation or 5q LOH was detected in hamartomatous polyps. These results suggest that gastrointestinal hamartomatous polyps in PJS patients develop through inactivation of the LKB1 gene by germ-line mutation plus somatic mutation or LOH of the unaffected LKB1 allele, and that additional mutations of the ß-catenin gene and p53 gene convert hamartomatous polyps into adenomatous and carcinomatous lesions.
This article has been cited by other articles:
![]() |
W. W J de Leng, A. M. Westerman, M. A J Weterman, M. Jansen, H. van Dekken, F. M Giardiello, F. W M de Rooij, J H Paul Wilson, G J. A Offerhaus, and J. J Keller Nasal polyposis in Peutz-Jeghers syndrome: a distinct histopathological and molecular genetic entity J. Clin. Pathol., April 1, 2007; 60(4): 392 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Schumacher, T Vogel, B Leube, C Driemel, T Goecke, G Moslein, and B Royer-Pokora STK11 genotyping and cancer risk in Peutz-Jeghers syndrome J. Med. Genet., May 1, 2005; 42(5): 428 - 435. [Full Text] [PDF] |
||||
![]() |
C. Wei, C. I. Amos, A. Rashid, M. Sabripour, L. Nations, T. J. McGarrity, and M. L. Frazier Correlation of Staining for LKB1 and COX-2 in Hamartomatous Polyps and Carcinomas from Patients with Peutz-Jeghers Syndrome J. Histochem. Cytochem., December 1, 2003; 51(12): 1665 - 1672. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. J. de Leng, A. M. Westerman, M. A. J. Weterman, F. W. M. de Rooij, H. v. Dekken, A. F. P. M. de Goeij, S. B. Gruber, J. H. P. Wilson, G. J. A. Offerhaus, F. M. Giardiello, et al. Cyclooxygenase 2 Expression and Molecular Alterations in Peutz-Jeghers Hamartomas and Carcinomas Clin. Cancer Res., August 1, 2003; 9(8): 3065 - 3072. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Rossi, A. Ylikorkala, N. Korsisaari, R. Salovaara, K. Luukko, V. Launonen, M. Henkemeyer, A. Ristimaki, L. A. Aaltonen, and T. P. Makela Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis PNAS, September 17, 2002; 99(19): 12327 - 12332. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tiainen, K. Vaahtomeri, A. Ylikorkala, and T. P. Makela Growth arrest by the LKB1 tumor suppressor: induction of p21WAF1/CIP1 Hum. Mol. Genet., June 15, 2002; 11(13): 1497 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Miyoshi, M. Nakau, T.-o Ishikawa, M. F. Seldin, M. Oshima, and M. M. Taketo Gastrointestinal Hamartomatous Polyposis in Lkb1 Heterozygous Knockout Mice Cancer Res., April 1, 2002; 62(8): 2261 - 2266. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |